| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,185,100 | 1,188,800 | 1,155,700 | 1,119,100 | | Cost of Revenue | 687,000 | 681,400 | 666,300 | 669,200 | | | Gross Profit | 498,100 | 507,400 | 489,400 | 449,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 247,300 | 237,300 | 233,800 | 226,400 | | Non Recurring |
-
| 10,200 |
-
| 4,200 | | Others | 15,900 | 15,200 | 15,100 | 14,900 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 234,900 | 244,700 | 240,500 | 204,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,900 | (300) | (100) | (11,900) | | Earnings Before Interest And Taxes | 238,100 | 248,300 | 243,200 | 193,600 | | Interest Expense | 15,000 | 16,200 | 17,000 | 18,000 | | Income Before Tax | 223,100 | 232,100 | 226,200 | 175,600 | | Income Tax Expense | 88,500 | 92,700 | 90,400 | 67,700 | | Minority Interest | (9,200) |
-
|
-
| (3,100) | | | | Net Income From Continuing Ops | 125,400 | 139,400 | 135,800 | 118,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 125,400 | 139,400 | 135,800 | 118,100 | | Preferred Stock And Other Adjustments | 6,000 | (3,000) | (3,000) |
-
| | | Net Income Applicable To Common Shares | $131,400 | $136,400 | $132,800 | $118,100 |
|
1.27% Nasdaq 
Income Statement
